DK0696325T3 - Fremgangsmåde til screening for tilstedeværelsen af en genetisk defekt knyttet til thrombose og/eller dårligt antikoagulere - Google Patents

Fremgangsmåde til screening for tilstedeværelsen af en genetisk defekt knyttet til thrombose og/eller dårligt antikoagulere

Info

Publication number
DK0696325T3
DK0696325T3 DK95909724T DK95909724T DK0696325T3 DK 0696325 T3 DK0696325 T3 DK 0696325T3 DK 95909724 T DK95909724 T DK 95909724T DK 95909724 T DK95909724 T DK 95909724T DK 0696325 T3 DK0696325 T3 DK 0696325T3
Authority
DK
Denmark
Prior art keywords
thrombosis
screening
genetic defect
defect associated
factor
Prior art date
Application number
DK95909724T
Other languages
English (en)
Inventor
Rogier Maria Bertina
Pieter Hendrik Reitsma
Original Assignee
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0696325(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leiden filed Critical Univ Leiden
Application granted granted Critical
Publication of DK0696325T3 publication Critical patent/DK0696325T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK95909724T 1994-02-14 1995-02-14 Fremgangsmåde til screening for tilstedeværelsen af en genetisk defekt knyttet til thrombose og/eller dårligt antikoagulere DK0696325T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94200377 1994-02-14
PCT/EP1995/000553 WO1995021938A1 (en) 1994-02-14 1995-02-14 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c

Publications (1)

Publication Number Publication Date
DK0696325T3 true DK0696325T3 (da) 1999-03-01

Family

ID=8216642

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97201766T DK0807691T3 (da) 1994-02-14 1995-02-14 Fremgangsmåde til screening for tilstedeværelse af en genetisk defekt forbundet med trombose og/eller lav antikoagulant reaktion på aktiveret protein C
DK95909724T DK0696325T3 (da) 1994-02-14 1995-02-14 Fremgangsmåde til screening for tilstedeværelsen af en genetisk defekt knyttet til thrombose og/eller dårligt antikoagulere

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK97201766T DK0807691T3 (da) 1994-02-14 1995-02-14 Fremgangsmåde til screening for tilstedeværelse af en genetisk defekt forbundet med trombose og/eller lav antikoagulant reaktion på aktiveret protein C

Country Status (14)

Country Link
US (3) US6518016B1 (da)
EP (2) EP0696325B1 (da)
JP (2) JP3163105B2 (da)
KR (1) KR100384251B1 (da)
AT (2) ATE206765T1 (da)
AU (1) AU690644B2 (da)
CA (1) CA2159907C (da)
DE (3) DE69523179T2 (da)
DK (2) DK0807691T3 (da)
ES (2) ES2166948T3 (da)
FI (1) FI117977B (da)
GR (2) GR960300034T1 (da)
PT (1) PT807691E (da)
WO (1) WO1995021938A1 (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935522A (en) * 1990-06-04 1999-08-10 University Of Utah Research Foundation On-line DNA analysis system with rapid thermal cycling
EP0815262A4 (en) * 1995-03-24 2000-08-23 Scripps Research Inst METHODS OF IDENTIFYING A MUTATION OF V FACTOR GENES
JPH11511021A (ja) * 1995-08-21 1999-09-28 アクゾ・ノベル・エヌ・ベー ｔ−ＰＡ多型および血栓関連疾患の危険度の診断におけるその用途
US20030143759A1 (en) * 1995-10-20 2003-07-31 Bjorn Dahlback Assays for determining anticoagulant cofactor activity
US5766869A (en) * 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
GB9604267D0 (en) * 1996-02-29 1996-05-01 Royal Infirmary Of Edinburgh N Mutation assay
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
AT404993B (de) * 1997-01-13 1999-04-26 Immuno Ag Verfahren zur bestimmung eines proteins mit einer mutation
US6451526B1 (en) * 1998-01-20 2002-09-17 Mayo Foundation For Medical Education And Research Simplified mutation detection
DE19802377A1 (de) 1998-01-22 1999-08-19 Max Planck Gesellschaft Verwendung von Inhibitoren für die Behandlung von RTK-Überfunktions-bedingten Störungen, insbesondere von Krebs
US6235480B1 (en) 1998-03-13 2001-05-22 Promega Corporation Detection of nucleic acid hybrids
US6270973B1 (en) 1998-03-13 2001-08-07 Promega Corporation Multiplex method for nucleic acid detection
US6335162B1 (en) 1998-03-13 2002-01-01 Promega Corporation Nucleic acid detection
US6270974B1 (en) 1998-03-13 2001-08-07 Promega Corporation Exogenous nucleic acid detection
US6391551B1 (en) 1998-03-13 2002-05-21 Promega Corporation Detection of nucleic acid hybrids
US6312902B1 (en) 1998-03-13 2001-11-06 Promega Corporation Nucleic acid detection
US6703211B1 (en) 1998-03-13 2004-03-09 Promega Corporation Cellular detection by providing high energy phosphate donor other than ADP to produce ATP
US7090975B2 (en) 1998-03-13 2006-08-15 Promega Corporation Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
US6268146B1 (en) 1998-03-13 2001-07-31 Promega Corporation Analytical methods and materials for nucleic acid detection
DE19840897A1 (de) * 1998-09-08 2000-03-09 Dirk Happich Faktor V-Leiden-Test
US6703228B1 (en) * 1998-09-25 2004-03-09 Massachusetts Institute Of Technology Methods and products related to genotyping and DNA analysis
EP1001037A3 (en) * 1998-09-28 2003-10-01 Whitehead Institute For Biomedical Research Pre-selection and isolation of single nucleotide polymorphisms
DE19848665A1 (de) * 1998-10-22 2000-04-27 Bayer Ag Ein automatisierbarer Schnelltest zum direkten Nachweis der APC Resistenz Mutation mit spezifischen Primern und Probes
CA2357011A1 (en) * 1999-02-18 2000-08-24 Promega Corporation Multiplex method for nucleic acid detection
US6238868B1 (en) * 1999-04-12 2001-05-29 Nanogen/Becton Dickinson Partnership Multiplex amplification and separation of nucleic acid sequences using ligation-dependant strand displacement amplification and bioelectronic chip technology
WO2000062036A1 (en) * 1999-04-12 2000-10-19 Nanogen/Becton Dickinson Partnership Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
WO2002046476A2 (en) * 2000-10-27 2002-06-13 Abbott Laboratories Genotyping using partially-complementary probes
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
CN1278096C (zh) * 2002-03-13 2006-10-04 博里利斯技术公司 用于检查管道形变的设备
US20030177850A1 (en) * 2002-03-19 2003-09-25 The Washington Post Company System and method for verifying the roll roundness of rolls of paper used for newspapers
US20050026168A1 (en) * 2002-12-13 2005-02-03 Genesis Group Inc. Method for the detection of risk factors associated with myocardial infarction
US20050032066A1 (en) * 2003-08-04 2005-02-10 Heng Chew Kiat Method for assessing risk of diseases with multiple contributing factors
FR2866349B1 (fr) * 2004-02-12 2008-05-16 Biomerieux Sa Procede de diagnostic/pronostic d'une thrombose
WO2006008267A2 (en) * 2004-07-16 2006-01-26 Novo Nordisk Health Care Ag Methods for optimizing forming viiia-based hemostatic treatment
EP1623996A1 (en) * 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved method of selecting a desired protein from a library
WO2006027111A1 (en) * 2004-09-06 2006-03-16 Zlb Behring Gmbh Modified coagulation factor viii with enhanced stability
KR100655658B1 (ko) * 2005-07-26 2006-12-08 삼성전자주식회사 게이트 전극 구조물과 그 제조 방법 및 이를 갖는 반도체트랜지스터와 그 제조 방법
JP2009523014A (ja) * 2006-01-12 2009-06-18 ザ ユニバーシティ オブ ブリティッシュ コロンビア 活性化プロテインｃ又はプロテインｃ様化合物投与に対する反応予測因子としてのプロテインｃパスウェイ関連多型性
WO2007098205A2 (en) * 2006-02-16 2007-08-30 The Hershey Company Cocoa products and methods of treating cardiovascular conditions with sugar-free cocoa
WO2008020090A1 (es) * 2006-08-18 2008-02-21 Laboratorios Indas, S.A. Método y kit para diagnosticar el riesgo de desarrollar una enfermedad trombótica venosa
US8636670B2 (en) * 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US9717896B2 (en) * 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US20090292213A1 (en) * 2008-05-21 2009-11-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090163856A1 (en) * 2007-12-19 2009-06-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Treatment indications informed by a prior implant information
US20100036263A1 (en) * 2008-08-07 2010-02-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090292214A1 (en) * 2008-05-22 2009-11-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090287120A1 (en) 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
EP2535424B1 (en) 2011-06-16 2015-08-05 Gendiag.exe, S.L. SNPs associated with thromboemoblic disease
WO2016005564A2 (en) * 2014-07-11 2016-01-14 Novo Nordisk A/S Antibodies against activated factor v

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049491A (en) * 1987-11-19 1991-09-17 The University Of Vermont Immunologic detection of factor V(VA) fragments in hemorrhagic and thrombotic clinical settings
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
SE470274B (sv) * 1991-11-13 1993-12-20 Bjoern Dahlbaeck Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
DE69207607T3 (de) * 1991-11-13 2006-07-06 T.A.C. Thrombosis And Coagulation Ab Verfahren zur diagnose von störungen der blutgerinnung
PL181102B1 (pl) 1993-01-29 2001-05-31 Dahlbaeck Bjoern Sposób oznaczania w próbce funkcjonalnej aktywności wybranego składnika koagulacji krwi
US5922855A (en) * 1993-12-17 1999-07-13 Oregon Health Sciences University Mammalian DNA mismatch repair genes MLH1 and PMS1
DK0756638T3 (da) 1994-04-22 2001-07-23 Sanquin Bloedvoorziening Midler til behandling af forstyrrelser i blodkoagulationskaskaden
US5639726A (en) * 1994-09-30 1997-06-17 The Regents Of The University Of Michigan Peptide mediated enhancement of thrombolysis methods and compositions
ES2154703T5 (es) 1994-11-10 2008-02-01 Dade Behring Marburg Gmbh Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
US5705395A (en) * 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
EP0815262A4 (en) 1995-03-24 2000-08-23 Scripps Research Inst METHODS OF IDENTIFYING A MUTATION OF V FACTOR GENES
US5874256A (en) * 1995-06-06 1999-02-23 Rijks Universiteit Leiden Method for diagnosing an increased risk for thrombosis or a genetic defect causing thrombosis and kit for use with the same
US5863896A (en) * 1995-11-09 1999-01-26 Immuno Ag Evaluation of substances for altering and for increasing APC response
US5766869A (en) * 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism

Also Published As

Publication number Publication date
WO1995021938A1 (en) 1995-08-17
FI117977B (fi) 2007-05-15
KR960702007A (ko) 1996-03-28
EP0696325A1 (en) 1996-02-14
DE69523179T2 (de) 2002-06-06
PT807691E (pt) 2002-04-29
CA2159907A1 (en) 1995-08-17
FI954855A (fi) 1995-11-17
ATE166110T1 (de) 1998-05-15
EP0807691B1 (en) 2001-10-10
ES2166948T3 (es) 2002-05-01
US5910576A (en) 1999-06-08
KR100384251B1 (ko) 2003-09-19
DE69523179D1 (de) 2001-11-15
DE69502451T2 (de) 1998-09-24
ATE206765T1 (de) 2001-10-15
EP0696325B1 (en) 1998-05-13
US6518016B1 (en) 2003-02-11
GR3027579T3 (en) 1998-11-30
JP3439458B2 (ja) 2003-08-25
GR960300034T1 (en) 1996-06-30
JPH08509383A (ja) 1996-10-08
DE696325T1 (de) 1996-08-29
US6558913B1 (en) 2003-05-06
EP0807691A3 (en) 1998-03-11
DE69502451D1 (de) 1998-06-18
ES2090001T1 (es) 1996-10-16
JP3163105B2 (ja) 2001-05-08
CA2159907C (en) 2006-12-12
AU1809195A (en) 1995-08-29
FI954855A0 (fi) 1995-10-12
ES2090001T3 (es) 1998-08-01
EP0807691A2 (en) 1997-11-19
DK0807691T3 (da) 2002-02-04
JP2001242170A (ja) 2001-09-07
AU690644B2 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
DK0696325T3 (da) Fremgangsmåde til screening for tilstedeværelsen af en genetisk defekt knyttet til thrombose og/eller dårligt antikoagulere
ATE529509T1 (de) Selektion von proteinen unter verwendung von rna- protein-fusionen
ATE311601T1 (de) Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
DK129588D0 (da) Fremgangsmaade til bestemmelse af nukleinsyrer samt reagenskombination og reagenssaet dertil
DE3682814D1 (de) Verfahren zur guetepruefung von glaswaren unter verwendung von optischem strichnachweis.
DK54690D0 (da) Fremgangsmaade af spektrofotometrisk art til kvantitativ bestemmelse af koncentrationen af en fortyndet komponent i et lys- eller straalingsspredende miljoe
DE68901632D1 (de) Reaktionsgefaess zur durchfuehrung von aufeinanderfolgenden analytischen testen.
ATE220341T1 (de) Verfahren zur trennung doppelsträngiger dna von einzelsträngiger dna oder rna
DE3587549D1 (de) Ergänzungstestverfahren von proteine bindenden enzymen.
DK203988D0 (da) Forbindelse, reagens og fremgangsmaade til bestemmelse af kationer
ATE69108T1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
DK0696642T3 (da) Fremgangsmåde til påvisning af forstyrrelser i protein C/protein S-systemet
DK0738735T3 (da) Aminoterminalt propeptid af type I procollagen, antistoffer dertil og analysemetode ved anvendelse deraf
DE69837399D1 (de) Verfahren zum screening von tgf-beta inhibierenden substanzen
ATE78873T1 (de) Verfahren zur selektiven spaltung von fusionsproteinen.
ATE64470T1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.
DE69000908D1 (de) Leichtes transportables brueckenteil zur ueberwindung von graeben.
DE59707874D1 (de) Bestimmung von analyten unter verwendung zweier markierungen
DE59309254D1 (de) Verwendung von Prothrombinfragmenten
DE69000909D1 (de) Transportables brueckenteil zur ueberwindung von graeben.
ATE77884T1 (de) Fluorometrischer test von chymopapain und reagenzien zur durchfuehrung desselben.
DE59105878D1 (de) VERFAHREN ZUR ENZYMATISCHEN SPALTUNG REKOMBINANTER PROTEINE UNTER VERWENDUNG VON IgA-PROTEASEN.
ATE85362T1 (de) Reagens zur pruefung von periodentalen erkrankungen.
ATE96227T1 (de) Mehrkanal-vorrichtung zur analysierung von molekulargasen unter verwendung der lasererregten raman-lichtstreuung.